Clinical Trial Update: Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial investigating the effects of glycine on symptoms and memory in schizophrenia and schizoaffective disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Glycine (glycine)

Snippet

Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: TERMINATED